Perrigo pays $93 million for Fera Pharmaceuticals' opthalmic products group Perrigo Company has acquired an opthalmic sterile products portfolio from Fera Pharmaceuticals, the generic drug and health-care products manufacturer announced. It paid $93 million in cash up front to complete the purchase of a opthalmic sterile ointment and solution product group.
June 18, 2013 - The Holland Sentinel